NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ: NTHI · Real-Time Price · USD
4.780
-0.055 (-1.14%)
May 28, 2026, 2:53 PM EDT - Market open
NTHI Revenue
In the year 2025, NeOnc Technologies Holdings had annual revenue of $39.99K, down -51.82%.
Revenue (ttm)
$39.99K
Revenue Growth
-51.82%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
121.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 39.99K | -43.01K | -51.82% |
| Dec 31, 2024 | 83.00K | 12.54K | 17.79% |
| Dec 31, 2023 | 70.46K | 50.46K | 252.31% |
| Dec 31, 2022 | 20.00K | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Black Diamond Therapeutics | 70.00M |
| Alpha Cognition | 10.83M |
| Coya Therapeutics | 7.94M |
| Cibus | 4.29M |
| Alps Group | 3.74M |
| Spruce Biosciences | 697.00K |
| Cardiff Oncology | 525.00K |
| Connect Biopharma Holdings | 233.00K |
NTHI News
- 9 days ago - NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones - GlobeNewsWire
- 9 days ago - NeOnc Technologies initiated with a Buy at Alliance Global - TheFly
- 10 days ago - NeOnc Provides Business Update and Reports Q1 2026 Financial Results - GlobeNewsWire
- 10 days ago - NeOnc Technologies initiated with a Buy at Maxim - TheFly
- 21 days ago - Biotech's Next Wave May Already be in Motion - GlobeNewsWire
- 22 days ago - Where Executives Are Doubling Down on Their Companies' Fortunes - GlobeNewsWire
- 23 days ago - NeOnc CEO Accelerates Insider Buying with $500K+ Investment Ahead of Imminent NEO100 Phase 2a Data Catalysts - GlobeNewsWire
- 4 weeks ago - NeOnc Technologies initiated with a Buy at BTIG - TheFly